nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Active parents, active youth? Exploring the association between physical activity of youth with Cystic Fibrosis and their parents
|
Kinaupenne, Manon |
|
|
24 |
2 |
p. 418-420 |
artikel |
2 |
Addressing pain in people living with cystic fibrosis: Cystic fibrosis foundation evidence-informed guidelines
|
Dellon, EP |
|
|
24 |
2 |
p. 224-235 |
artikel |
3 |
Advertisement for Editor-in-Chief, Journal of Cystic Fibrosis
|
|
|
|
24 |
2 |
p. 201-202 |
artikel |
4 |
AI-facilitated home monitoring for cystic fibrosis exacerbations across pediatric and adult populations
|
Mazurek, Henryk |
|
|
24 |
2 |
p. 390-397 |
artikel |
5 |
Association of race and ethnicity with the development of cystic fibrosis-related diabetes
|
Rayas, Maria S. |
|
|
24 |
2 |
p. 263-270 |
artikel |
6 |
Associations between income level and health outcomes in people with cystic fibrosis in Turkey
|
Metin Cakar, Neval |
|
|
24 |
2 |
p. 295-300 |
artikel |
7 |
Characteristics of individuals with cystic fibrosis in the United States ineligible for ivacaftor and elexacaftor/tezacaftor/ivacaftor
|
Sanders, Don B. |
|
|
24 |
2 |
p. 255-262 |
artikel |
8 |
Characterization of 223 infants with CFTR-related metabolic syndrome/Cystic fibrosis screen positive, inconclusive diagnosis (CRMS/CFSPID) identified during the first three years of newborn screening via IRT-DNA-SEQ in New York State
|
Sadeghi, Hossein |
|
|
24 |
2 |
p. 404-411 |
artikel |
9 |
Contents
|
|
|
|
24 |
2 |
p. i-iv |
artikel |
10 |
Coping and learning to Manage Stress with cystic fibrosis (CALM): A multisite telehealth randomized controlled trial to reduce depression and anxiety symptoms in adults with cystic fibrosis
|
Bathgate, Christina J. |
|
|
24 |
2 |
p. 310-318 |
artikel |
11 |
Corrigendum to “Evaluation of the response to elexacaftor-tezacaftor-ivacaftor of the rare CFTR variants L383S, I507del, L1065P and R1066H in intestinal organoid-derived epithelial monolayers” [Journal of Cystic Fibrosis xxx (2025) 1–10]
|
Conti, Jessica |
|
|
24 |
2 |
p. 429 |
artikel |
12 |
Cystic fibrosis year in review 2024
|
Alameeri, Amel |
|
|
24 |
2 |
p. 218-223 |
artikel |
13 |
Daily variability of Pseudomonas aeruginosa density in cystic fibrosis sputum
|
Carmody, Lisa A. |
|
|
24 |
2 |
p. 341-344 |
artikel |
14 |
Disparities in outcomes by race and ethnicity in the Canadian cystic fibrosis population
|
Holland, Rachel |
|
|
24 |
2 |
p. 271-277 |
artikel |
15 |
Elexacaftor/tezacaftor/ivacaftor and mental health: A workshop report from the Cystic Fibrosis Foundation's Prioritizing Research in Mental Health working group
|
Bathgate, CJ |
|
|
24 |
2 |
p. 301-309 |
artikel |
16 |
From the editor's desk
|
Flume, Patrick A |
|
|
24 |
2 |
p. 205-211 |
artikel |
17 |
GRASPing for answers: The shortfalls of our current understanding of the effects of GI-related aspiration on the lungs in CF (GRASP-CF)
|
Vélez, Christopher |
|
|
24 |
2 |
p. 398-400 |
artikel |
18 |
Impact of UPLIFT, a group telehealth intervention, on symptoms of depression and anxiety in adults with CF
|
Schechter, Michael S. |
|
|
24 |
2 |
p. 319-325 |
artikel |
19 |
Infection prevention and control in cystic fibrosis: An update of a systematic review of interventions
|
Rowbotham, Nicola J |
|
|
24 |
2 |
p. 359-363 |
artikel |
20 |
Letter in response to letter
|
Schechter, Dr. Michael |
|
|
24 |
2 |
p. 427-428 |
artikel |
21 |
Letter to the Editor: Additional considerations for addressing pain in people living with cystic fibrosis
|
Ward, Anastasia |
|
|
24 |
2 |
p. 423-424 |
artikel |
22 |
Mental health and adherence in CF: Self-efficacy and perceived barriers as mediators
|
Everhart, Robin S. |
|
|
24 |
2 |
p. 334-340 |
artikel |
23 |
Monitoring cystic fibrosis airway infections with Pseudomonas aeruginosa with anti-OprF serum antibodies
|
Tümmler, Burkhard |
|
|
24 |
2 |
p. 353-358 |
artikel |
24 |
Mycobacterium abscessus biofilm cleared from murine lung by monoclonal antibody against bacterial DNABII proteins
|
Jurcisek, Joseph A. |
|
|
24 |
2 |
p. 374-381 |
artikel |
25 |
Mycobacterium abscessus treatment outcomes in cystic fibrosis: A single centre experience
|
Evans, Ieuan |
|
|
24 |
2 |
p. 364-367 |
artikel |
26 |
News article
|
|
|
|
24 |
2 |
p. 203-204 |
artikel |
27 |
Pain in adults with cystic fibrosis – Are we painfully unaware?
|
Ward, Anastasia |
|
|
24 |
2 |
p. 236-245 |
artikel |
28 |
Pain is a constant in our lives with CF: Please believe us
|
Elshaar, Noor |
|
|
24 |
2 |
p. 421-422 |
artikel |
29 |
Pf bacteriophage is associated with decline in lung function in a longitudinal cohort of patients with cystic fibrosis and Pseudomonas airway infection
|
Burgener, Elizabeth B. |
|
|
24 |
2 |
p. 345-352 |
artikel |
30 |
Pseudo-Bartter syndrome: A CFTR-related disorder?
|
Rodriguez Mier, Noelia |
|
|
24 |
2 |
p. 401-403 |
artikel |
31 |
Race, genetic ancestry, and socioeconomic status – a tangled web
|
Schechter, Michael S. |
|
|
24 |
2 |
p. 215-217 |
artikel |
32 |
Racial disparities in lung transplantation for cystic fibrosis in the era of highly effective modulator therapy
|
Ruck, Jessica M. |
|
|
24 |
2 |
p. 278-283 |
artikel |
33 |
Real-world outcomes of generic elexacaftor/tezacaftor/ivacaftor (gETI) in South Africans (SA) with CF using standard versus clarithromycin-boosted gETI, modulator-sparing strategies to reduce cost
|
Zampoli, Marco |
|
|
24 |
2 |
p. 284-289 |
artikel |
34 |
Response to editorial
|
Magaret, Amalia S. |
|
|
24 |
2 |
p. 425-426 |
artikel |
35 |
Strategies used to access CFTR modulators in countries without reimbursement agreements
|
Guo, Jonathan |
|
|
24 |
2 |
p. 290-294 |
artikel |
36 |
Supporting adherence to the cystic fibrosis regimen: Development and validation of The Daily Care Check-In (DCC)
|
Riekert, Kristin A. |
|
|
24 |
2 |
p. 326-333 |
artikel |
37 |
Sweat chloride reflects CFTR function and correlates with clinical outcomes following CFTR modulator treatment
|
Zemanick, Edith T. |
|
|
24 |
2 |
p. 246-254 |
artikel |
38 |
The fungal diversity in the lungs of children with cystic fibrosis captured by sputum-induction and bronchoalveolar lavage
|
Weiser, Rebecca |
|
|
24 |
2 |
p. 382-389 |
artikel |
39 |
The multiple tales on sweat chloride in cystic fibrosis
|
Tümmler, Burkhard |
|
|
24 |
2 |
p. 212-214 |
artikel |
40 |
Tolerability and effectiveness of face-masks in reducing cough aerosols for children with cystic fibrosis
|
Tay, George T.P. |
|
|
24 |
2 |
p. 368-373 |
artikel |
41 |
Using heart rate data from wrist worn activity trackers to define thresholds for moderate to vigorous physical activity in children and young people with cystic fibrosis
|
Tanriver, Gizem |
|
|
24 |
2 |
p. 412-417 |
artikel |